Literature DB >> 9420138

Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva.

J D Macleod1, D F Anderson, S M Baddeley, S T Holgate, J I McGill, W R Roche.   

Abstract

BACKGROUND: Recently, the potential role of mast cells in allergic reactions has been extended by the discovery that these cells synthesize, store and secrete multifunctional cytokines. Seasonal allergic conjunctivitis is characterized as an immediate hypersensitivity reaction, in which allergen binds to specific IgE on mast cells, leading to release of pre-formed and newly synthesized inflammatory mediators.
OBJECTIVE: In this study we aimed to localize the cytokines IL-4, IL-5, IL-6, IL-8 and TNF alpha to conjunctival mast cells and to examine the relationship between mast cell-associated cytokines and allergic conjunctivitis.
METHODS: Immunohistochemistry was performed on serial sections of conjunctival biopsies from patients with seasonal allergic conjunctivitis, in and out of the hay fever season, as well as from non-allergic volunteers.
RESULTS: IL-4, IL-5, IL-6 and TNF alpha were localized to mast cells in normal and allergic conjunctiva. IL-8 was localized to mast cells in two patients with seasonal allergic conjunctivitis, one during and the other outside the pollen season. Using the monoclonal antibody 3H4, which identifies the secreted form of IL-4, biopsies from patients with active seasonal allergic conjunctivitis contained a significantly higher proportion of mast cells positive for IL-4, than those from out-of-season patients (P=<0.016). There was no difference between the two groups in the number of mast cells immunostained by the antibody 4D9 which identifies the stored form of IL-4.
CONCLUSIONS: These results suggest that conjunctival mast cells can store a range of multifunctional cytokines and release IL-4 during active disease, which may give them an important role in upregulating allergic inflammation in the conjunctiva.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9420138

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  11 in total

Review 1.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 2.  Allergic eye disease mechanisms.

Authors:  J I McGill; S T Holgate; M K Church; D F Anderson; A Bacon
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

3.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

Review 4.  A review of the use of olopatadine in allergic conjunctivitis.

Authors:  James I McGill
Journal:  Int Ophthalmol       Date:  2004-05       Impact factor: 2.031

Review 5.  Epithelial cells in ocular allergy.

Authors:  Murat Irkeç; Banu Bozkurt
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

Review 6.  Pathophysiology of ocular allergy: the roles of conjunctival mast cells and epithelial cells.

Authors:  James L Stahl; Ellen B Cook; Neal P Barney; Frank M Graziano
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

Review 7.  The central role of conjunctival mast cells in the pathogenesis of ocular allergy.

Authors:  Andrea Leonardi
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

Review 8.  Basic science and pathophysiology of ocular allergy.

Authors:  Virginia L Calder; Peter M Lackie
Journal:  Curr Allergy Asthma Rep       Date:  2004-07       Impact factor: 4.919

9.  The effect of ketotifen on inflammatory markers in allergic conjunctivitis: an open, uncontrolled study.

Authors:  Andrea P Martín; Julio Urrets-Zavalia; Alejandro Berra; Ana Lía Mariani; Norberto Gallino; Eduardo Gomez Demel; Julio Gagliardi; Carlos E Baena-Cagnani; Enrique Urrets-Zavalia; Horacio M Serra
Journal:  BMC Ophthalmol       Date:  2003-01-06       Impact factor: 2.209

10.  Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells.

Authors:  Megan E Cavet; Stepan Volhejn; Karen L Harrington; Jin-Zhong Zhang
Journal:  Mol Vis       Date:  2013-07-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.